Scott Brooks, from Maltby, was just 17 when he started smoking, saying it was just "the norm" for the 1980s. But after ...

A new nasal spray treatment being developed by FIU researchers could slow Parkinson's disease progression, offering hope for a major shift beyond symptom management.

Parkinson’s disease is a neurodegenerative disorder characterized by the progressive loss of dopamine-producing nerve cells in the brain, leading to motor slowing, gait and balance problems and ...

AI robots like this one from Boston Dynamics now handle real jobs in Hyundai plants, marking the 2026 shift from lab demos to daily operations ...

New research highlights the impact of ageing-related inflammation, especially due to immune cells marked by the GZMK gene, first seen in people affected by severe COVID. View on euronews ...

Tozorakimab is an investigational monoclonal antibody designed to bind and inhibit interleukin-33 (IL-33), an alarmin cytokine. This targeted approach is expected to reduce airway inflammation and ...

Among adults with COPD, those with vs. without cost-related nonadherence had worse symptom burden, health status and lung ...

(NAPSI)—Chronic obstructive pulmonary disease (COPD) affects approximately 16 million Americans and can make even simple ...

While the Netherlands was in lockdown because of the coronavirus, Ph.D. candidate Koen Rijpkema began his research into the ...

People living with HIV face a greater risk of developing lung diseases at a much younger age, even if they have never smoked.

AstraZeneca (AZN) stock is in focus as tozorakimab marks a new Phase 3 trial win in chronic obstructive pulmonary disease, a ...